Skip to main content
. 2021 Jul 28;83(4):473–482. doi: 10.1016/j.jinf.2021.07.034

Table 2.

Epidemiological and genomic evidence for nosocomial acquisition of SARS-CoV-2 based on classification of 803 PCR-positive hospital in-patients.

Definite nosocomial Probable nosocomial Indeterminate Community-onset
Epidemiological evidence
Standard epidemiological classification* 51 58 79 615
Enhanced epidemiological classification provides support for nosocomial acquisition (n,%)⁎⁎ Yes No Yes No Yes No Yes No
51 (100%) 0 56 (97%) 2 (3%) 53 (67%) 26 (33%) 89 (14%) 526 (86%)
Donor/recipient closest epidemiological link identifiedWard contactHospital contact 465 00 533 20 512 242 6920 00
Combined epidemiological and genomic evidence
Recipient and one or more epidemiological donor(s) sequenced (n,%)^Ward contactHospital contact 25/46 (54%)1/5 (20%) 00 37/53 (70%)2/3 (67%) 1/2 (50%)0 29/51 (57%)1/2 (50%) 15/24 (63%)1/2 (50%) 37/69 (54%)5/20 (25%) 00
Genomic linkage confirmed (n,%)^^Ward contactHospital contact 17/25 (68%)1/1 (100%) 00 32/37 (86%)1/2 (50%) 1/1 (100%)0 22/29 (76%)1/1 (100%) 6/15 (40%)0/1 (0%) 17/37 (46%)0/5 (0%) 00

Nosocomial classification according to national Public Health England definition.

⁎⁎

Enhanced epidemiological classification for nosocomial acquisition, using prior negative PCR in the same admission, or previous hospital admission during the incubation period to provide additional support for nosocomial acquisition. Figures demonstrate number and% of nosocomial category.

^Figures presented as number sequenced over total number of recipients with one or more ward or hospital contacts identified

^^Figures presented as number genomically linked over total number of recipients sequenced, for ward contacts or hospital contacts.